Remove Gene Therapy Remove Genomics Remove Packaging Remove Sales
article thumbnail

IN FOCUS: Solvias

Pharmaceutical Technology

In regards to the latter, notable examples include the acquisition of Cergentis, a genomics-focused biotechnology company based in the Netherlands. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.

article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

. Affinia Therapeutics raises $110 million for gene therapy treatments ( STAT ). New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). Startup sets out to tackle the gene therapy manufacturing crisis ( Endpoints ). Medtech.